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ABSTRACT
In the field of pharmaceuticals, the crystallization process significantly impacts the purity, morphology and
polymorphism of active pharmaceutical ingredients (API), all of which are important in drug development.
Polymorphism is the existence of more than one solid-state form of the same chemical entity. Tolfenamic
acid (TFA), a Non-Steroid Anti-inflammatory drug (NSAID), has been shown to exhibit a unique physical
phenomenon called concomitant polymorphism, whereby two polymorphs crystallize from the solution
simultaneously. From previous work, it has been established that solution speciation i.e. the presence of
monomers or dimers of TFA in solution is concentration and temperature dependent. This study
correlates this existing solution speciation with the crystallization outcome by analyzing the ratio of
polymorphs obtained at different temperatures at a fixed concentration. Polymorphic purity was examined
using powder X-ray diffraction. Crystallization experiments were performed at 10°C, 37°C, and 55°C at a
constant supersaturation ratio of 1.95. Samples were taken at various time points in the recrystallization
process. These samples were examined using Infrared spectroscopy for solid-state composition and
quantified using a calibration curve. Pure polymorphs of TFA have been obtained and a calibration curve
to quantify phase composition has been established. The initial recrystallization results suggest that the
conformation of the crystals in solution is decided by the composition of the initial crystals formed,
however more experimentation is necessary. Ongoing work involving recrystallization experiments under
different temperature conditions would lead to a much better understanding of the role of solution
speciation in the nucleation and crystallization processes.

KEYWORDS
Crystallization, Pharmaceuticals, Polymorphs, Solid-State, Tolfenamic Acid, Nucleation

REFERENCES
Newman, A. and Byrn, S. (2003) Solid-State analysis of the active pharmaceutical ingredient in drug
products. DDT, 8, 898-905
Mattei, A., and Li, Tonglei. (2012) Polymorph Formation and Nucleation Mechanism of Tolfenamic Acid
in Solution: An Investigation of Pre-nucleation Solute Association. Pharm Res, 29, 460-470
Mattei, A. et al. (2013) Two Major Pre-Nucleation Species that are Conformationally Distinct and in
Equilibrium of Self-Association. J. Cryst. Growth, 13, 3303-3307
Mattei, A. and Li, T. (2011) Interplay between molecular conformation and intermolecular interaction in
conformational polymorphs: A molecular perspective from electronic calculations of tolfenamic acid. Int.
J. of Pharm. 418, 179-186

